Skip to main content
Back to Investors

Elaia Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Elaia Investment Overview

Portfolio Companies
123
Total Invested
$1.1B
Average Investment
$14.4M

Elaia's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
dottxt2024Seed$8.7MRidgewood
Continuity2024Series A$10.9MParis
Descartes & Mauss2024Series Unknown$6.0MNew York
BIOPHTA2024Seed$7.1MParis
FlexAI2024Seed$30.5MParis
Pixacare2024Series Unknown$3.2MStrasbourg
Nijta2024Pre-Seed$2.2MLille
HEPHAISTOS-Pharma2024Seed$4.9MOrsay
Phospho2024Pre-Seed$1.7MParis
SUN ZU Lab2024Seed$1.8MMetz

Complete List of Elaia Portfolio Companies (123)

Export
#CompanyStageAmountLocation
76dottxtSeed$8.7MRidgewood, United States
77ContinuitySeries A$10.9MParis, France
78Descartes & MaussSeries Unknown$6.0MNew York, United States
79BIOPHTASeed$7.1MParis, France
80FlexAISeed$30.5MParis, France
81PixacareSeries Unknown$3.2MStrasbourg, France
82NijtaPre-Seed$2.2MLille, France
83HEPHAISTOS-PharmaSeed$4.9MOrsay, France
84PhosphoPre-Seed$1.7MParis, France
85SUN ZU LabSeed$1.8MMetz, France
Artificial Intelligence (AI)Developer APIsNatural Language ProcessingSoftware

Dottxt offers machine language models for information extraction and classification via API.

Ridgewood, United States
August 2024
$8.7M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)SaaS

Continuity, uses AI to help insurances improve underwriting for SME’s.

Paris, France
June 2024
$10.9M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)ConsultingInformation Technology

Descartes & Mauss is an AI-powered growth consulting firm that combines advanced data modeling capabilities with a creative methodology.

New York, United States
June 2024
$6.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical Device

BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

Paris, France
June 2024
$7.1M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Information TechnologyIntelligent Systems

Intelligent Compute. Infinite Possibilities.

Paris, France
April 2024
$30.5M
Seed

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceSaaS

Digital wound care management

Strasbourg, France
April 2024
$3.2M
Series Unknown

Founder Contacts

19,000+ verified contacts

Web Development

Nijta provides a robust and secure speech anonymization solution to contact centers.

Lille, France
March 2024
$2.2M
Pre-Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyOncology

Hephaistos Pharma is a biotech company developing oncology treatments.

Orsay, France
January 2024
$4.9M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Information TechnologySoftwareSoftware Engineering

phospho is an AI startup that provides developers and businesses access to generative AI solutions

Paris, France
January 2024
$1.7M
Pre-Seed

Founder Contacts

19,000+ verified contacts

AnalyticsCryptocurrencyInformation Technology

SUN ZU Lab is an independent provider of quantitative analytics for crypto professionals.

Metz, France
January 2024
$1.8M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Financial ServicesHealth CareInformation TechnologySoftware

i-Virtual develops an advanced AI-powered solution that enables touchless measurement of vital signs through a simple image or video capture

Metz, France
December 2023
$3.2M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Developer ToolsGenerative AISaaSSearch EngineSoftware

Tabnine is an AI coding assistant that accelerates and simplifies the software development process without sacrificing privacy and security.

Tel Aviv, Israel
November 2023
$25.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Big Data

Fentech offers platform for Decision Intelligence that guarantees reliable forecasting.

Paris, France
October 2023
$1.3M
Seed

Founder Contacts

19,000+ verified contacts

GamingHealth CareMedicalMedical Device

Tilak build a series of fun medical games to change the way we monitor chronic diseases.

Paris, France
October 2023
$10.5M
Series A

Founder Contacts

19,000+ verified contacts

Cyber SecurityNetwork SecuritySoftware

HarfangLab develops a hunting software to boost detection and neutralization of cyberattacks against companies endpoints.

Paris, France
October 2023
$26.4M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical Device

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations.

Paris, France
July 2023
$14.3M
Series A

Founder Contacts

19,000+ verified contacts

AdvertisingArtificial Intelligence (AI)Carbon CaptureSoftware

Greenbids is an AI-powered media buying optimization platform that enhances digital advertising performance while reducing carbon emissions.

Paris, France
June 2023
$1.7M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceutical

Mablink Bioscience is a biotechnology company.

Lyon, France
October 2022
$30.1M
Series A

Founder Contacts

19,000+ verified contacts

Cloud ComputingCloud Data ServicesCloud InfrastructureCloud ManagementIT InfrastructureSoftware

PaaS, Cloud Edge Orchestration Platform

Massy, France
October 2022
$1.2M
Pre-Seed

Founder Contacts

19,000+ verified contacts

SaaS

The Safer, Easier Way to Work with People Outside of Your Organization

Paris, France
October 2022
$2.9M
Seed

Founder Contacts

19,000+ verified contacts

Data CenterData IntegrationData Storage

Corporatings specializes in extracting and processing structured and non-structured fundamental data directly from company publications.

Paris, France
September 2022
$2.0M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health DiagnosticsMachine LearningMedical DeviceSoftware

Therapixel is a software company specialized in artificial intelligence for medical imaging analysis

Nice, France
May 2022
$15.6M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftware

Nuclia, the Agentic RAG-as-a-Service company.

Barcelona, Spain
April 2022
$5.4M
Seed

Founder Contacts

19,000+ verified contacts

Software

Blindnet is a startup building next-generation data privacy and security solutions.

New York, United States
April 2022
$1.3M
Pre-Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Information TechnologyInsuranceInsurTechMachine Learning

Shift Technology is a provider of AI-driven decision automation and optimization technology for the global insurance industry.

Paris, France
November 2021
Series D

Founder Contacts

19,000+ verified contacts

Showing 76-100 of 123 portfolio companies

Frequently Asked Questions About Elaia

How many companies has Elaia invested in?

Elaia has invested in 123 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Elaia invest in?

Elaia's top investment sectors include Artificial Intelligence (AI), Software, Information Technology, Health Care, Medical Device. The firm invests across 40 different industry categories.

What is Elaia's largest investment?

Among tracked funding rounds, FlexAI received $30.5M in a Seed round. Elaia's total known invested capital is $1.1B.

What is the average investment size for Elaia?

Elaia's average investment size is $14.4M across its portfolio of 123 companies.

What are Elaia's most recent investments?

Recent Elaia portfolio additions include dottxt, Continuity, Descartes & Mauss, BIOPHTA, FlexAI. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors